Removing the ripcord from a glaucoma drainage device after 3 months

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with open-angle glaucoma who have an Ahmed Clear Path or Baerveldt drainage device with a ripcord are evaluated after ripcord removal to see how intraocular pressure changes over time. IOP is measured before removal, 30 minutes after, and at 1 week, 6 weeks, and 3 months during routine clinic visits. The procedure is performed at Duke Eye Center and participation is voluntary. The study aims to determine if late ripcord removal affects glaucoma control.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years
* Placement of Ahmed Clear Path or Baervelt drainage device with ripcord \> 3 months
* Diagnosis of Glaucoma, under active management at Duke Eye Center Glaucoma Clinic
* Ripcord suture still in place and accessible for removal
* Able to provide written informed consent
* IOP \> 10 mm Hg

Exclusion Criteria:

* Active ocular infection or conjunctivitis in either eye
* Inability to undergo ripcord removal procedure
* Scheduled for further glaucoma surgery

Where it's running

• Duke University Eye Center
  Durham, North Carolina, United States Recruiting

Study contacts

• Principal investigator: Leon W Herndon, MD — Duke University Eye Center
• Study coordinator: Jonathan Shepherd
• Email: j_shepherd0829@email.campbell.edu
• Phone: (919) 681-3937

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Long-Term Results After Ab-interno Trabeculotomy for Glaucoma

  This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.

  Recruiting Wuerzburg University Hospital · Würzburg, Bavaria · NCT07780916

• Balance training for people with glaucoma

  A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07910955

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients

  This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.

  Recruiting Tomey Corporation · Jacksonville, Florida · NCT07804277

• Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing

  This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07802769

• Cross-modal cerebellar stimulation to improve balance and vision in glaucoma

  In older adults with glaucoma, this study tests whether different cerebellar transcranial electrical stimulation methods can improve balance and visual-cognitive function.

  Recruiting The Hong Kong Polytechnic University · Kowloon, Hong Kong · NCT07771699

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.